Search Results
F.I.R.M.O. Italian Foundation for the Research on Bone Diseases, Florence, Italy
Search for other papers by Francesca Marini in
Google Scholar
PubMed
Search for other papers by Francesca Giusti in
Google Scholar
PubMed
Search for other papers by Teresa Iantomasi in
Google Scholar
PubMed
Search for other papers by Federica Cioppi in
Google Scholar
PubMed
Search for other papers by Maria Luisa Brandi in
Google Scholar
PubMed
Introduction Multiple endocrine neoplasia type 1 (MEN1) is a rare, autosomal-dominant inherited cancer syndrome characterized by the development, during the lifetime of a patient, of multiple tumors in target neuroendocrine and non-endocrine
Search for other papers by Sara Lomelino Pinheiro in
Google Scholar
PubMed
Search for other papers by Ana Saramago in
Google Scholar
PubMed
Search for other papers by Branca Maria Cavaco in
Google Scholar
PubMed
Search for other papers by Carmo Martins in
Google Scholar
PubMed
Search for other papers by Valeriano Leite in
Google Scholar
PubMed
Search for other papers by Tiago Nunes da Silva in
Google Scholar
PubMed
hyperparathyroidism (FIHP; CDC73/HRPT2 and GCM2 genes) and, rarely, in multiple endocrine neoplasia type 1 (MEN1, MEN1 gene) and 2A (MEN2A; RET gene) ( 2 , 3 ). MEN1 is a rare disorder characterized by PHPT, pituitary and gastroenteropancreatic
Parathyroid Unit – LIM-28, Laboratório de Cirurgia de Cabeça e Pescoço, Division of Head and Neck Surgery, Department of Surgery, Hospital das Clinicas (HCFMUSP), University of São Paulo School of Medicine (FMUSP), Faculdade de Medicina, Universidade de São Paulo, São Paulo, São Paulo, Brazil
Search for other papers by Marília D’Elboux Guimarães Brescia in
Google Scholar
PubMed
Endocrine Oncology Division, Institute of Cancer of the State of São Paulo (ICESP), University of São Paulo School of Medicine (FMUSP), Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, São Paulo, Brazil
Search for other papers by Karine Candido Rodrigues in
Google Scholar
PubMed
Search for other papers by André Fernandes d’Alessandro in
Google Scholar
PubMed
Search for other papers by Wellington Alves Filho in
Google Scholar
PubMed
Search for other papers by Willemijn Y van der Plas in
Google Scholar
PubMed
Search for other papers by Schelto Kruijff in
Google Scholar
PubMed
Search for other papers by Sergio Samir Arap in
Google Scholar
PubMed
Search for other papers by Sergio Pereira de Almeida Toledo in
Google Scholar
PubMed
Search for other papers by Fábio Luiz de Menezes Montenegro in
Google Scholar
PubMed
Endocrine Oncology Division, Institute of Cancer of the State of São Paulo (ICESP), University of São Paulo School of Medicine (FMUSP), Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, São Paulo, Brazil
Search for other papers by Delmar Muniz Lourenço Jr in
Google Scholar
PubMed
Background Multiple endocrine neoplasia type 1 (MEN1) (#131100) is an autosomal dominant inherited syndrome mainly caused by germline mutations in the MEN1 tumoral suppressor gene ( 1 , 2 ). Most mutation carriers will develop at least one
Search for other papers by Ruth Therese Casey in
Google Scholar
PubMed
Search for other papers by Deborah Saunders in
Google Scholar
PubMed
Search for other papers by Benjamin George Challis in
Google Scholar
PubMed
Search for other papers by Deborah Pitfield in
Google Scholar
PubMed
Search for other papers by Heok Cheow in
Google Scholar
PubMed
Search for other papers by Ashley Shaw in
Google Scholar
PubMed
Search for other papers by Helen Lisa Simpson in
Google Scholar
PubMed
Introduction Multiple endocrine neoplasia type 1 (MEN1) is a hereditary endocrine neoplasia syndrome characterised by autosomal dominant inheritance of mutations in MENIN , a tumour suppressor gene. Patients with MEN1 typically develop
Search for other papers by Elena Pardi in
Google Scholar
PubMed
Search for other papers by Stefano Mariotti in
Google Scholar
PubMed
Search for other papers by Natalia S Pellegata in
Google Scholar
PubMed
Search for other papers by Katiuscia Benfini in
Google Scholar
PubMed
Search for other papers by Simona Borsari in
Google Scholar
PubMed
Search for other papers by Federica Saponaro in
Google Scholar
PubMed
Search for other papers by Liborio Torregrossa in
Google Scholar
PubMed
Search for other papers by Antonello Cappai in
Google Scholar
PubMed
Search for other papers by Chiara Satta in
Google Scholar
PubMed
Search for other papers by Marco Mastinu in
Google Scholar
PubMed
Search for other papers by Claudio Marcocci in
Google Scholar
PubMed
Search for other papers by Filomena Cetani in
Google Scholar
PubMed
Introduction Multiple endocrine neoplasia type 1 (MEN1, OMIM #131100) is a rare autosomal dominant endocrine disorder characterized by the occurrence of parathyroid adenoma/hyperplasia, duodeno–pancreatic neuroendocrine tumors (NETs), and anterior
Search for other papers by Dirk-Jan van Beek in
Google Scholar
PubMed
Search for other papers by Rachel S van Leeuwaarde in
Google Scholar
PubMed
Search for other papers by Carolina R C Pieterman in
Google Scholar
PubMed
Search for other papers by Menno R Vriens in
Google Scholar
PubMed
Parelsnoer Institute, Utrecht, The Netherlands
Search for other papers by Gerlof D Valk in
Google Scholar
PubMed
Search for other papers by the DutchMEN Study Group in
Google Scholar
PubMed
are scarce or the underlying scientific evidence is meager. Multiple endocrine neoplasia type 1 (MEN1) (OMIM 131100) is an autosomal dominant disease with an estimated occurrence rate of 2–3 per 100,000 ( 2 ). Due to the complexity of the disease
Search for other papers by Cristina Lamas in
Google Scholar
PubMed
Search for other papers by Elena Navarro in
Google Scholar
PubMed
Search for other papers by Anna Casterás in
Google Scholar
PubMed
Search for other papers by Paloma Portillo in
Google Scholar
PubMed
Search for other papers by Victoria Alcázar in
Google Scholar
PubMed
Search for other papers by María Calatayud in
Google Scholar
PubMed
Search for other papers by Cristina Álvarez-Escolá in
Google Scholar
PubMed
Search for other papers by Julia Sastre in
Google Scholar
PubMed
Search for other papers by Evangelina Boix in
Google Scholar
PubMed
Search for other papers by Lluis Forga in
Google Scholar
PubMed
Search for other papers by Almudena Vicente in
Google Scholar
PubMed
Search for other papers by Josep Oriola in
Google Scholar
PubMed
Search for other papers by Jordi Mesa in
Google Scholar
PubMed
Search for other papers by Nuria Valdés in
Google Scholar
PubMed
Introduction Multiple endocrine neoplasia type 1 (MEN1) syndrome is a rare hereditary disease, with an estimated prevalence of 0.15–0.30 cases per 1000 in general population ( 1 , 2 ). Primary hyperparathyroidism (PHPT) is its most common
Search for other papers by Hélène Singeisen in
Google Scholar
PubMed
Search for other papers by Mariko Melanie Renzulli in
Google Scholar
PubMed
Search for other papers by Vojtech Pavlicek in
Google Scholar
PubMed
Search for other papers by Pascal Probst in
Google Scholar
PubMed
Search for other papers by Fabian Hauswirth in
Google Scholar
PubMed
Search for other papers by Markus K Muller in
Google Scholar
PubMed
Search for other papers by Magdalene Adamczyk in
Google Scholar
PubMed
Search for other papers by Achim Weber in
Google Scholar
PubMed
Search for other papers by Reto Martin Kaderli in
Google Scholar
PubMed
Search for other papers by Pietro Renzulli in
Google Scholar
PubMed
Introduction Multiple endocrine neoplasia (MEN) is a rare group of autosomal dominant disorders with a wide spectrum of endocrine and non-endocrine manifestations ( Table 1 ). Five different types of MEN have been described so far: MEN1, MEN2
Search for other papers by Weixi Wang in
Google Scholar
PubMed
Search for other papers by Rulai Han in
Google Scholar
PubMed
Search for other papers by Lei Ye in
Google Scholar
PubMed
Search for other papers by Jing Xie in
Google Scholar
PubMed
Search for other papers by Bei Tao in
Google Scholar
PubMed
Search for other papers by Fukang Sun in
Google Scholar
PubMed
Search for other papers by Ran Zhuo in
Google Scholar
PubMed
Search for other papers by Xi Chen in
Google Scholar
PubMed
Search for other papers by Xiaxing Deng in
Google Scholar
PubMed
Search for other papers by Cong Ye in
Google Scholar
PubMed
Search for other papers by Hongyan Zhao in
Google Scholar
PubMed
Search for other papers by Shu Wang in
Google Scholar
PubMed
Introduction Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disease characterized by the presence of endocrine tumors mainly affecting parathyroid, pituitary and pancreatic islet. Adrenal lesions occur in 20–55% of MEN1
Search for other papers by Arnaud Lagarde in
Google Scholar
PubMed
Search for other papers by Grégory Mougel in
Google Scholar
PubMed
Search for other papers by Lucie Coppin in
Google Scholar
PubMed
Search for other papers by Magalie Haissaguerre in
Google Scholar
PubMed
Inserm/CNRS UMR 1283/8199, Pasteur Institute of Lille, EGID, Lille, France
Search for other papers by Lauriane Le Collen in
Google Scholar
PubMed
Search for other papers by Amira Mohamed in
Google Scholar
PubMed
Search for other papers by Marc Klein in
Google Scholar
PubMed
Univ. Lille, Inserm, CHU Lille, U1286 – Infinite – Institute for Translational Research in Inflammation, Lille, France
Search for other papers by Marie-Françoise Odou in
Google Scholar
PubMed
Search for other papers by Antoine Tabarin in
Google Scholar
PubMed
Search for other papers by Hedia Brixi in
Google Scholar
PubMed
Search for other papers by Thomas Cuny in
Google Scholar
PubMed
Search for other papers by Brigitte Delemer in
Google Scholar
PubMed
Search for other papers by Anne Barlier in
Google Scholar
PubMed
Search for other papers by Pauline Romanet in
Google Scholar
PubMed
Introduction Multiple endocrine neoplasia type 1 (MEN1, OMIM 131100) is an autosomal dominant disease due to mutation in the MEN1 gene, characterized by a broad spectrum of clinical manifestations ( 1 ). The classic clinical triad includes